Stimulation programs for pediatric drug research--do children really benefit?
about
Children are not just small adults: the urgent need for high-quality trial evidence in childrenHow to improve the implementation of academic clinical pediatric trials involving drug therapy? A qualitative study of multiple stakeholdersClinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conferenceErosive and cariogenicity potential of pediatric drugs: study of physicochemical parametersChallenges in conducting clinical trials in children: approaches for improving performanceStatus of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry.Analysis of pediatric clinical drug trials for neuropsychiatric conditionsMethods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies.Paediatric clinical pharmacology in the UK.Framework conditions facilitating paediatric clinical research.Clinical trials in childrenPlacebo-controlled trials in pediatrics and the child's best interest.The availability and age-appropriateness of medicines authorized for children in The Netherlands.Pharmacokinetic research in children: an analysis of registered records of clinical trials.An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.Academic pediatric clinical research: factors associated with study implementation durationDrug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry.Recent developments and strategies in pediatric pharmacology research in the USA.Use of non-formulary drugs in children at a Brazilian teaching hospital: a descriptive study.The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions.Off-label prescribing for allergic diseases in children.Towards evidence-based pharmacotherapy in children.Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control.The status of paediatric medicines initiatives around the world--What has happened and what has not?Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review.Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study.Trends in the number and the quality of trial protocols involving children submitted to a French Institutional Review BoardRegulation of drugs for children in Europe.Improving the Helsinki Declaration's guidance on research in incompetent subjects.Regulating "higher risk, no direct benefit" studies in minorsNeonatal drug trials: impact of EU and US paediatric regulationsAdolescents in Clinical TrialsPaediatric drug policy in Australia
P2860
Q28473435-7E474BD9-EBAC-462A-9689-3B6418CEEFD4Q28533359-601C4CC7-57CA-463E-B209-8532D1C03C23Q28703857-29D1241D-A108-429E-985B-F3F8CABDB7F5Q33643979-15AD0E1C-2937-4B11-A242-6599E5896FFFQ33717140-8EF5577C-3D13-4967-B0F5-5AA531B5FB10Q33819664-15E8E78E-6A76-496B-9E55-F648D9E8DD19Q33819758-16E5C2CB-1022-4961-B596-7689A64C6BE6Q34351816-FC49CD39-AD6C-4737-A363-B911EE9E2A5EQ34607600-3297590B-470D-49B5-8C5F-A8CA58B912FCQ34662520-2A0F3D8F-58A9-4D9C-B9FA-34EE6A31B768Q35135928-7DD225FF-BBBD-4ACC-A2FD-F202C355B49AQ35136434-763F09B3-303B-4198-AC39-60FCB37614C6Q35219667-AC900E1D-C604-4DA0-AC1D-ED5CA066ACF3Q35322451-6E9D80A2-DA9D-4F27-8726-7FD42A3F2D73Q35545776-D82C7D6F-2A8C-4E57-AD2C-B923FC630DCBQ35973230-D212A787-A4B6-42C8-89B1-EC919D05436FQ36278708-A723D89E-845F-497A-AB42-4BD6E5E7101CQ37040160-8A601BA6-D39C-4D13-924E-09ECBF023284Q37190965-2628E013-084D-492E-B2AF-6ADD83FE2F2DQ37228107-A1ECC494-B78A-4133-8D0A-DF023258F997Q37592152-2916E903-72BB-484B-88E6-0E9C705C68DAQ37825584-CB374E47-1CC8-4B4B-99C2-46EC6A989509Q37846890-62B27C2C-68BC-4F32-B7C9-A48C9E4A7D1EQ37898039-FA00B7B9-7AAA-46A6-8AF2-2C05459507A2Q38260525-656F6614-5B40-4F58-93C8-FE3362CBD515Q40193019-5CA9F8D2-D5E6-4783-A863-3FE6C79EA827Q41507403-F8FF0A28-3EC9-4080-9F6D-9009EE516246Q42824007-955237B3-8F6F-4974-B064-9AB10CEEEA5BQ48173596-2A6A50FD-F8C5-4197-8766-98CF004883CBQ56776993-B88BC80E-A6FD-4EAC-AC09-7030CD514E16Q57413139-244D3B34-E1BD-4BD5-8F70-21B989C162F1Q58392299-84A38F80-0074-4062-AB27-27E27FE11A49Q59167441-12522F16-3524-4430-9348-63DA88A99CC9
P2860
Stimulation programs for pediatric drug research--do children really benefit?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Stimulation programs for pediatric drug research--do children really benefit?
@ast
Stimulation programs for pediatric drug research--do children really benefit?
@en
type
label
Stimulation programs for pediatric drug research--do children really benefit?
@ast
Stimulation programs for pediatric drug research--do children really benefit?
@en
prefLabel
Stimulation programs for pediatric drug research--do children really benefit?
@ast
Stimulation programs for pediatric drug research--do children really benefit?
@en
P2093
P2860
P1476
Stimulation programs for pediatric drug research--do children really benefit?
@en
P2093
Adam F Cohen
Isabelle Boots
Jacobus Burggraaf
Richard H Klein
Robert A Holl
Rám N Sukhai
P2860
P2888
P304
P356
10.1007/S00431-006-0381-Z
P577
2007-01-17T00:00:00Z